Atherosclerosis (AS) is a chronic inflammatory disease with the formation and accumulation of macrophage‐derived foam cells in the subendothelial space of blood vessels as one major characteristic. Insulin‐like growth factor 2 messenger RNA (mRNA) binding protein 1 (IGF2BP1) is an RNA‐binding factor and its elevation has been reported to be associated with macrophage infiltration into the atherosclerotic vascular wall. This study aims to investigate the roles of IGF2BP1 in AS‐associated foam cell formation. Herein, ApoE−/− mice fed with high‐fat diet developed atherosclerotic lesions in the aorta, where IGF2BP1 expression was upregulated and autophagy was impaired. IGF2BP1 expressed in F4/80+ macrophages and coexisted with p62. In vitro, IGF2BP1 expression was upregulated in RAW264.7 macrophages exposed to oxidized low‐density lipoprotein (ox‐LDL) (100 μg/ml). Interestingly, silencing of IGF2BP1 ameliorated ox‐LDL‐induced lipid accumulation and inflammation, and enhanced autophagic flux in macrophages. Furthermore, the expression of RUNX family transcription factor 1 (RUNX1), a gene that is able to inhibit autophagy in multiple cell types, was elevated in atherosclerotic aortas and in ox‐LDL‐treated macrophages. In addition, RNA immunoprecipitation results revealed that IGF2BP1 is bound to RUNX1 mRNA. Alterations induced by IGF2BP1 knockdown in ox‐LDL‐treated macrophages were abolished by RUNX1 overexpression. Furthermore, after autophagy inhibitor 3‐methyladenine administration, silencing of IGF2BP1‐reduced lipid accumulation and inflammation were recovered in RAW264.7 cells. In summary, our study demonstrated that silencing of IGF2BP1 restrained ox‐LDL‐induced lipid accumulation and inflammation by reducing RUNX1 expression and facilitating autophagy in macrophages. IGF2BP1/RUNX1 axis may be considered as a potential therapeutic target in AS.